Novel systemic immune data demonstrated T-cell activation following local administration of aglatimagene. Together with recently disclosed evidence of persistent local immune remodeling, these ...
Beginning in the early 2000s, immune checkpoint inhibitors (ICIs) began to reshape cancer treatment and improve outcomes for ...
T cells are not the only attackersWhen people hear about immunotherapy for blood cancers, many may think of CAR-T cell ...
Triple-negative breast cancer has long been one of the most stubborn targets in oncology. Lacking the estrogen receptor, ...
The following is a repost from Facebook by Professor Takayoshi Shimohata, Department of Neurology, Gifu University Graduate ...
Immune checkpoint inhibitors such as anti-PD-1 and anti-CTLA-4 antibodies have transformed the treatment of many cancers, yet ...
TCRαβ⁺CD4⁻CD8⁻ double-negative T cells (DNTs) are a subset of T lymphocytes with unique anti-tumor potential, capable of directly killing various ...
Agenus is now a pure-play on its BOT/BAL cancer immunotherapy, with all resources focused on the upcoming ROBBIN Phase 3 ...
Cloud-Clone Enables Clinical Validation of Circulating OGN Biomarker in Nature Cell Biology-Published Research HUSTON, ...
The overall death rate from cancer dropped roughly thirty percent over two decades. Public health shifts like reduced smoking ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results